← Evidence map

ArticleOncotarget2016

Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer.

K Adam Morrow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26908451